) Ve hay sts OU) 1e index to Volume 60 is composed of three parts: a subject Statements and Guidelines, are indexed under “American Soci iuthor index, and an advertising index. ety of Health-System Pharmacists,” as well as being covered by t index is made up mainly of terms constructed by IPA in many cases. The subject index also notes all regular AJHP -harmaceutical Abstracts (IPA The JPA index is an columns and, under the respective column headings, the titles of open-ended, controlled-vocabulary index that items in the following: Book Reviews, Editorials, Frontline Phar standardized headings. (The primary index terms macist, Letters, Management Consultation, News, and Q&A. The le are listed routinely in AJHP as “index terms” after subject index also contains, t heading “Correction No [PA covers all authored papers and editorials in AJHP, tices,” the title and issue of publication of items for which correc | as selected letters and news reports. Items that were pub tions were printed, as well as the page numbers on which the the ASHP Reports section, including official ASHP corrections appear. issue August | 101—208 \ugust 15 209-296 August 15 Supplement 29 402 September | 103-498 September 15 499-622 October | 623-718 October 15 23-2160 719—850 October | 5 Supplemen 1-833 851-964 November | Z>2 08 965-1062 November | Supplement $22 S1 | November | .) 2? 2380 1063-1 November ;1 5 Supple 1193-12 December | 1289-] December | Supplem S1-S2 December | ) 1387 2 December 15 Sup plen > Supplpiee n S] Africa Alzheimer’s disease Subject Index Age Ambisome Amphotericin B Ambulatory care 4J/HP Continuing Education, 44 Albumin Albuterol cidental! falls American Association of Colleges of Nursing Accreditatior American Association of Colleges of Pharmacy Alemtuzumab American College of Cardiology Alfuzosin hydrochloride American College of Physicians Alkalinizing agents American Council on Pharmaceutical Education Allergies American Heart Association American Journal of Health-System Pharmacy Allopurinol Alteplase Alternative medicine American Nurses Association American Organization of Nurse Executives Alternative therapies Advertising Index a Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 2615 em Pharmacists Antibodies Anticoagulants convulsants Antitub Antituss Antivi Antidepressants Antidiabetic agents s and hypnotics stamines Antiintective agents Antiinflammatory agents Angiotensin converting e T nhibitors Antilipemic agents Angiotensin-conver Anthracyclines Antiinfective agents Antineoplastic agents Atropine Antiinflammatory agents t Audiovist Antibiotics Automation 2616 Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 erebrovascular dis ertification alcitonin hemical warfar alcium herry syrup alcium antagonists hitosan Poliglus alcium carbonate iprofloxacin alcium chloride lindamycin phosphate alcium gluconate linical pharmacists alcium regulators linical pharmacy aloric agents linical studies alvino, | Carbamazepine lonazepam Cardiac drugs Momordica charantia lothing lozapine Blood odes Blood der olor Blood level ardiopulmonary bypass ardiopulmonary resuscitation ombined therapy ardiovascular diseases book Correctior Notice ardiovascular drugs Book Reviews areer Opportunities areers armustine arriers Commentaries ase Management Committees Law Communication aspoftungin acetate efazolin Cetepime Compliance Cetotaxime Ceftriaxone Celecoxib Centers for Medicare and Medicaid Services Compounding Central nervous system drugs Central nervous system stimulants Books Received Bone density Cephalosporins Budgets Buspirone Cerebrovascular accidents ee ————_—_—_$_$ Am J Health-Syst Pharm—Vol 60 Dec 15,2003 | 2617 and Human Services 2618 ; Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 Drug administration routes Drugs Dissolution Diuretics Drug comparisons Vocumentation Drug distribution Dolasetron availabilit Drug distribution systems Drugs, body distribution Drug information Drug information centers Drugs, counterfeit Drug interactions Drugs, over the cour Dyskinesia Dyspepsia Economics Dosage schedules xapram hydrochloride Editorials Edrecolomab Education Drug withdrawal Drug administration rate Am J Health-Syst Pharm—Vol 60 Dec 15,2003 | 2619 Excretion Gastrointestin Education, {| Gastroint Gefitinib xpiration dates Gemfib Gemtu Fenoldopam mesylate entanyl tropin errous sulfate exofenadine Finasteride conazole Mist Influenza vac unisolid aFoll k medi,c ine idaparinux Drug Administr Formulations Erythropoieti estrogen *harmacist Ethnic grou Ethosuximide G Excipients Galantamine hydrobromide Ganciclovir Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 Health centers Health Insurance Portability and Accountability Act s, adverse reactions, 4 Immunomodulating agents Health maintenance organizations Health professionals fs } \u supp 5 Immunosuppressive agents Health professions Imports Incompatibilities Health Resources and Services Administration Health-benefit programs Hours Humatrope, Somatropin Industry, pharmaceutical Hearing loss Hydrocortisone sodium succinate Heart arrest Hydrogen ion concentration } Infectious Disease Society of America Heart failure Infliximab Influenza vaccines Hypercholesterolemia Informed consent Hyperglycemia Heart valve prosthesis Inhalers Hyperkalemia Hematopoietic agents Hyperlipidemia Injections Hemophilia Hemorrhage Hypertension Heparin sodium Hypokalemia History Hypoprothrombinemias Hypotensive agents HIV infections Institute of Medicine Insulin Ho—me tests Ibritumomab tiuxetan insulins Homeland Security Act ibutilide Interleukin | receptor antagonist see Anakinra Homeless Fp ersons ’ r International normalized ratio Identification Hormones International Normalized Ratio Ifosfamide : : International Pharmaceutical Federation Illinois Hospitals . Internet Imatinib mesylate Immunization — ‘ - Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 2621 Levalbuter Levofloxa Levothyroxine Liability Lidocain Lamotrigi Legislation Lepirudin Medco Medical Reserve Corps Leukotriene antagonists Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 INDEN Medicare Pharmacist Services Coverage Act Momordica charantia Medication orders Mortality Medicine ) Myocardial infarction N embership Naloxone hydrochloride Nanoparticles Membranes ; Nasal preparations Menopat F National Asthma Education and Prevention Program isorders National Cholesterol Education Program S National Health Service ¢ ~<a National Institutes of Health National Patient Safety Foundation National Quality Forum Nausea Nefazodone Neoplasm vaccines Neoplasms Neoprene Neostigmine methylsulfate Nesiritide Networks Neutropenia Milrinone 1OMA rreeppoorrtt s esidencies retair Minimum inhibitory concentration payment, 1933 »b for Missouri pharmacist Am J Health-Syst Pharm—Vol 60 Dec 15, 2003 | 2623 Ofloxacin Olanzapine Patients Opiate antagonists Opiates Pediatrics Ora plus Ora sweet Organizations Osmolality enetration > enicill|i ns Osteomyelitis Peppermint Oste oporosis ermeabilit Permeat yn Outcomes . Personne Personn Packaging Pharmaceu aclitaxel Pain maceu h and Manufacturers of Amer PhRMA Niacin Pantoprazole Pharmacet Nicotine . Papaverine NifedipEi ne Parasympatholytic agents Nimodip Parasympathomimetic agents Nizatidine . Parathyroid Nomenclature Parathyroid hormones Norditropin Somatropir Patient care Nurse practitioners Nurses Pharmas Nutraceuticals Nutrition Nutropin AQ Somz Patient education 0 Obesity Patient information Odors onsultation, 473, 65 336, Jul 1s 2624 Am J Health-Syst Pharm—Vol 60 Dec 15, 2003